December 14, 2016 / 5:26 PM / a year ago

U.S. files first charges in generic drug price-fixing probe - Bbg

Dec 14 (Reuters) - The U.S. Department of Justice accused two executives of Heritage Pharmaceuticals Inc of colluding with other generic drugmakers to fix prices, the first criminal charges stemming from a sweeping two-year investigation, Bloomberg reported.

Heritage Pharmaceuticals' former chief executive, Jeffrey Glazerof, and an ex-president, Jason Malek, were charged in Philadelphia on Wednesday, Bloomberg reported, citing court filings. (bloom.bg/2hFD6PS)

Shares of generic drugmakers such as Mylan NV, Endo International Plc and Teva Pharmaceutical Industries Ltd tumbled after the report.

A representative from Heritage Pharmaceuticals, based in Eatontown, New Jersey, was not immediately available for comment. (Reporting by Ankur Banerjee in Bengaluru; Editing by Savio D‘Souza)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below